Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 52, Issue 6, 2011, Pages 1118-1126

  Canalle, Renata ^a   Silveira, Vanessa S ^b   Alberto Scrideli, Carlos ^b   Queiroz, Rosane G P ^b   Fernando Lopes, Luiz ^c   Gonzaga Tone, Luiz ^b  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

childhood ALL; ERCC2; Genetic polymorphisms; susceptibility; TYMS; XRCC1

Indexed keywords

THYMIDYLATE SYNTHASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CODON; CONTROLLED STUDY; DNA REPAIR; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; BRAZIL; CHILD; CHILD, PRESCHOOL; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; THYMIDYLATE SYNTHASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 79957445440     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.559672     Document Type: Article

References (54)

1. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999;35:1941-1953. (Pubitemid 30026216)
2. Pui CH. Acute lymphoblastic leukemia in children. Curr Opin Oncol 2000;12:3-12.
3. Bolufer P, Barragan E, Collado M, Cervera J, López JA, Sanz MA. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 2006;30:1471-1491. (Pubitemid 44573473)
4. Canalle R, Burim RV, Tone LG, Takahashi CS. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 2004;43:100-109. (Pubitemid 38332725)
5. Silveira Vda S, Canalle R, Scrideli CA, Queiroz RG, Tone LG. Role of the CYP2D6, EPHX1, MPO, and NEnviron Mol Mutagen 2010;51:48-56QO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children.
6. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786-3791. (Pubitemid 34534552)
7. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 2005;217:17-24. (Pubitemid 39642862)
8. Zanrosso CW, Hatagima A, Emerenciano M, et al. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 2006; 30:477-481. (Pubitemid 43254969)
9. Pakakasama S, Sirirat T, Kanchanachumpol S, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;48:16-20. (Pubitemid 44871587)
10. Kamb A, Finer-Moore J, Calvert AH, Stroud RM. Structural basis for recognition of polyglutamyl folates by thymidylate synthase. Biochemistry 1992;31:9883-9890.
11. Hori T, Ayusawa D, Shimizu K, Koyama H, Seno T. Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells. Cancer Res 1984;44:703-709. (Pubitemid 14184608)
12. Hori T, Ayusawa D, Glover TW, Seno T. Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cells. Jpn J Cancer Res 1985; 76:977-983. (Pubitemid 16198822)
13. Chu E, Allegra CJ. The role of thymidylate synthase in cellular regulation. Adv Enzyme Regul 1996;36:143-163. (Pubitemid 27065709)
14. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:129-132. (Pubitemid 30073783)
15. Danenberg PV, Malli H, Swenson S. Thymidylate synthase inhibitors. Semin Oncol 1999;26:621-631. (Pubitemid 30013269)
16. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 50-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995;20: 191-197.
17. Marsh S, Ameyaw MM, Githanga J, Indalo A, Ofori-Adjei D, McLeod HL. Novel thymidylate synthase enhancer region alleles in African populations. Hum Mutat 2000;16: 528.
18. Chen J, Hunter DJ, Stampfer MJ, et al. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2003;12:958-962. (Pubitemid 37310249)
19. Koppen IJ, Hermans FJ, Kaspers GJ. Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia. Br J Haematol 2010;148:3-14.
20. Hishida A, Matsuo K, Hamajima N, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003;88:159-166. (Pubitemid 37101493)
21. Shi Q, Zhang Z, Neumann AS, Li G, Spitz MR,Wei Q. Casecontrol analysis of thymidylate synthase polymorphisms and risk of lung cancer. Carcinogenesis 2005;26:649-656. (Pubitemid 41214156)
22. Krajinovic M, Costea I, Chiasson S. Polymorphism of the thymidylate synthase gene and outcome of acute lymphocytic leukemia. Lancet 2002;359:1033-1034. (Pubitemid 34286543)
23. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD. Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 2000;9:1381-1385. (Pubitemid 32044809)
24. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-1530. (Pubitemid 36020002)
25. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-608. (Pubitemid 28099464)
26. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:125-131. (Pubitemid 32172431)
27. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2001;10:217-222. (Pubitemid 34288532)
28. Hao B, Wang H, Zhou K, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004;64:4378-4384. (Pubitemid 38802447)
29. Zhang X, Miao X, Liang G, et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 2005;65:722-726. (Pubitemid 40216429)
30. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 2005;217: 17-24. (Pubitemid 39642862)
31. Taylor EM, Broughton BC, Botta E, et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 1997;94:8658-8663. (Pubitemid 27335095)
32. Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007;4:59-71. (Pubitemid 46238636)
33. Clarkson SG, Wood RD. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair 2005;4:1068-1074. (Pubitemid 41316584)
34. Xing D, Tan W, Wei Q, Lin D. Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer 2002;38:123-129. (Pubitemid 35157754)
35. Sturgis EM, Zheng R, Li L, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000;21:2219-2223. (Pubitemid 32049228)
36. Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 2001;22: 403-408. (Pubitemid 32203818)
37. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13:23-29. (Pubitemid 38116616)
38. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999;59:2557-2561. (Pubitemid 29269097)
39. Marsh S, Collie-Duguid ES, Li T, Liu X,McLeod HL. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 1999;58:310-312. (Pubitemid 29300314)
40. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of earlyonset colorectal carcinoma in Egypt. Cancer Lett 2000;159: 79-86.
41. Yin J, Li J, Vogel U, Wang H. Polymorphisms of DNA repair genes: ERCC1 G19007A and ERCC2/XPD C22541A in a northeastern Chinese population. Biochem Genet 2005;43: 543-548. (Pubitemid 41778742)
42. Canalle R, da Silva S Andrade V, Scrideli CA, de Paula Queiroz RG, Tone LG. Polymorphisms in the thymidylate synthase promoter and the DNA repair genes XRCC1 and XPD in a Brazilian population. Environ Mol Mutagen 2006;47:725-732. (Pubitemid 44917685)
43. Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based casecontrol study. Carcinogenesis 2006;27:1377-1385. (Pubitemid 43985413)
44. Giovannetti E, Ugrasena DG, Supriyadi E, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk Res 2008;32:19-24. (Pubitemid 350100830)
45. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-897. (Pubitemid 30429188)
46. Anderson LM. Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge. Mutat Res 2006;608:136-156. (Pubitemid 44322063)
47. Batar B, Güven M, Bar?ş S, Celkan T, Y?ld?z I. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2009;33: 759-763.
48. Zhu R, Lu FJ, Zhang ZB, et al. Association of genetic polymorphism of XRCC1 with susceptibility to acute childhood leukemia. Wei Sheng Yan Jiu 2005;34:300-302.
49. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-3295.
50. Bolufer P, Collado M, Barragán E, et al. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 2007;92:308-314. (Pubitemid 350143539)
51. Gast A, Bermejo JL, Flohr T, et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007;21:320-325. (Pubitemid 46158126)
52. Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. A populationbased case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1462-1467. (Pubitemid 38031750)
53. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a casecontrol study. Lancet 2001;358:1935-1940. (Pubitemid 34072874)
54. Zahm SH, Fraumeni JF Jr. Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ Health Perspect 1995;103:283-286. (Pubitemid 26040915)